ask="100.00"
ask_size="500"
average_daily_volume="301150"
bid="20.15"
bid_size="100"
book_value="3.79"
change="-0.49"
change_from_200_day_moving_average="3.10"
change_from_50_day_moving_average="0.43"
change_from_52_week_high="-3.99"
change_From_52_week_low="13.69"
change_in_percent="-1.73%"
close="27.81"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="14358000"
high="28.25"
high_52_weeks="31.80"
last_trade_date="2/15/2017"
last_trade_price="27.81"
last_trade_size="3508"
last_trade_time="4:00pm"
low="27.53"
low_52_weeks="14.12"
market_capitalization="596.02M"
moving_average_200_day="24.71"
moving_average_50_day="27.38"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="28.25"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="+12.55%"
percent_change_from_50_day_moving_average="+1.56%"
percent_change_from_52_week_high="-12.55%"
percent_change_from_52_week_low="+96.95%"
previous_close="28.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.47"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.47"
stock_exchange="NMS"
symbol="ACRS"
volume="144822"
weeks_range_52="14.12 - 31.80"
